Лечение клинически локализованного рака предстательной железы

1. Kirby R. Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting. Nat Clin Pract Urol 2005;2(6):298—303.

2. Lepor H., Nieder A.M., Ferrandino M.N. Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases. J Urol 2001;166(5):1729—33.

3. Heinzer H., Hammerer P., Graefen M. et al. Thromboembolic complication rate after radical retropubic prostatectomy. Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas. Eur Urol 1998;33(1):86—90.

4. Pepper R.J., Pati J., Kaisary A.V. The incidence and treatment of lymphoceles after radical retropubic prostatectomy. BJU Int 2005;95(6):772—5.

5. Solberg A., Angelsen A., Bergan U. et al. Frequency of lymphoceles after open and laparoscopic pelvic lymph node dissection in patients with prostate cancer. Scand J Urol Nephrol 2003;37(3):218—21.

6. Partin A.W., Mangold L.A., Lamm D.M. et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58:843—8.

7. Roberts W.W., Bergstralh E.J., Blute M.L. et al. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology 2001;57:1033—7.

8. King C.R. Patterns of prostate cancer biopsy grading trends and clinical implications. Int J Cancer 2000;90:305—11.

9. Miyake H., Kurahashi T., Takenaka A. et al. Improved accuracy for predicting the gleason score of prostate cancer by increasing the number of transrectal biopsy cores. Urol Int 2007;79:302—6.

10. Hsu C.Y., Joniau S., Oyen R. et al. Detection of clinical unilateral T3a prostate cancer — by digital rectal examination or transrectal ultrasonography? BJU Int 2006;98(5):982—5.

11. Potosky A.L., Legler J., Albertsen P.C. et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the prostate Cancer outcomes study. J Nat Cancer Inst 2000;92(19):1582—92.

12. Madalinska J.B., Essink-Bot M.L., de Koning H.J. et al. Quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol 2001;19(6):1619—28.

13. Bianco F.J., Grignon D.J., Sakr W.A. et al. Radical prostatectomy with bladder neck preservation: impact of a positive margin. Eur Urol 2003;43(5):461—6.

14. Selli C., De Antoni P., Moro U. et al. Role of bladder neck preservation in urinary continence following radical retropubic prostatectomy. Scand J Urol Nephrol 2004;38(1):32—7.

15. Nandipati K.C., Raina R., Agarwal A. et al. Nerve-sparing surgery significantly affects long-term continence after radical prostatectomy. Urology 2007;70(6):1127—30.

16. Wagner A.A., Link R.E., Trock B.J. et al. Comparison of open and laparoscopic radical prostatectomy outcomes from a surgeon's early experience. Urology 2007;70(4):667—71.

17. Kundu S.D., Roehl K.A., Eggener S.E. et al. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004;172(6):2227—31.

18. Alibhai S.M., Leach M., Warde P.R. Major early complications after radical radiotherapy (RT) among 8,615 men: impact of age, comorbidity, and time. Proc ASCO 2005;abstr 98.

19. Claudio J. et al. Survival after radical prostatectomy and radiotherapy: a population-based study of 17,570 men. AUA 2007;abstr 380.

20. Kattan M.W., Wheeler T.M., Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17(5):1499.